Health
Moderna Announces First Participants Dosed in Study Evaluating COVID-19 Booster Vaccine Candidates – Yahoo Finance
Moderna announces first participants dosed in study evaluating COVID-19 booster vaccine candidates.
Study to enroll 60 participants previously vaccinated with mRNA-1273 in Phase 2, to evaluate booster vaccine candidates against the B.1.351 variant first identified in South Africa
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participants have been dosed with the Companys modified COVID-19 vaccines, designed to address the potential need for booster vaccine candidates, in an amendment to the ongoing…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
General19 hours agoTrump’s AUKUS review coming soon. Will he stop the folly?